Jewel Samad/Agence France-Presse/Getty Images
U.S. stocks rose Friday as investors remained optimistic over prospects for another round of fiscal stimulus from Congress, with major benchmarks on track for their best week since August.
What are major benchmarks doing?
The Dow Jones Industrial Average (DJIA) rose 107.54 points, or 0.4%, to 28,533.05, while the S&P 500 (SPX) advanced 18.21 points, or 0.5%, to 3,465.04. The Nasdaq Composite (COMP) gained 83.45 points, or 0.7%, to 11,504.43.
The Dow on Thursday rose 122.05 points, or 0.4%, to finish at 28,425.51, while the S&P 500 advanced 27.38 points, or 0.8%, to close at 3,446.83. The Nasdaq Composite finished at 11,420.98, up 56.38 points, or 0.5%.
Through Thursday, the Dow was on track for a 2.7% weekly gain, while the S&P 500 was up 2.9% and the Nasdaq was up 3.1%. That would be the strongest weekly rise for the Dow since Aug. 7 and the strongest for the S&P 500 and Nasdaq since Aug. 28, according to FactSet.
What’s driving the market?
Investors remain optimistic about another fiscal stimulus package being passed by Congress eventually and stocks advanced Thursday encouraged by continued talks between House Democrats and the Trump administration.
House Speaker Nancy Pelosi, D-California, on Thursday rejected calls for stand-alone aid for airlines, saying any relief must be part of a broader package, but talks continued, with Pelosi and Treasury Secretary Steven Mnuchin holding further discussions. A Pelosi spokesman tweeted that Mnuchin had signaled the administration was now again open to a comprehensive package.
Stocks had taken a tumble on Tuesday after President Donald Trump announced he had ended talks on a stimulus package until after the election, but a few hours later he changed course to call for action on piecemeal stimulus efforts, and now wants a broader package again. Senate Republicans remain hesitant to increase the fiscal deficit further though.
“Investors have clearly been sensitive to the on/off fiscal stimulus talks, as U.S. equities appear primarily driven by expectations surrounding the outcome of these intense discussions,” said Han Tan, market analyst at FXTM, in a note.
“Amid the drama between the White House and Democrats, which add to the political shenanigans leading up to the November presidential elections, it’s evident that investors are clinging on to any sliver of hope that the world’s largest economy will see additional fiscal aid,” he said.
Analysts said Democratic challenger Joe Biden’s widening lead in the polls over President Donald Trump has also been seen as a supportive factor because it lessens, but doesn’t eliminate, the prospect of a contested election outcome on Nov. 3, a prospect that has unnerved investors fearing weeks of legal and political wrangling. The president trails Joe Biden by an average of 9.7 percentage points nationally according to the Real Clear Politics average of polling.
COVID-19 treatment hopes were also in focus, analysts said. Gilead Sciences Inc. (GLD) said late Thursday that a late-stage study of its experimental COVID-19 treatment showed it shortened time to recovery. The drug, remdesivir, was reportedly one of the medications recently prescribed to President Donald Trump for his COVID-19 infection. Gilead shares rose 1.4%.
The U.S. economic calendar is light Friday, with data on August wholesale inventories due at 10 a.m. Eastern.
Which companies are in focus?
What are other markets doing?
Mainland Chinese stocks jumped as investors returned from a weeklong break, with the Shanghai Composite (CN:SHCOMP) rising 1.7%. Japan’s Nikkei 225 index (JP:NIK) rose 0.1%, while Hong Kong’s Hang Seng Index (HK:HSI) gained 0.3%.
The yield on the 10-year Treasury note (BX:TMUBMUSD10Y) rose 1.4 basis points to 0.781%.
Oil futures (CRUD) pulled back but remained on track for a 10% weekly rise as Hurricane Delta approached the Louisiana Gulf Coast. Gold (GOLD) was up 1.5%, pushing back above $1,900 an ounce and turning positive for the week.
The ICE U.S. Dollar Index (DXY) a measure of the currency against six major rivals, was down 0.5%.